Roche unveils New York research base
September 26, 2012Research and Development New York, Nutley, Roche, translational research
Roche is to locate a new translational clinical research centre in central New York, as part of a shift towards …
Trajenta added to insulin recommended in Europe
September 26, 2012Sales and Marketing Boehringer Ingelheim, Trajenta, diabetes
The CHMP has recommended that Boehringer Ingelheim and Eli Liily and Co’s diabetes brand Trajenta should be approved as add-on …
Sanofi to cut 900 jobs in France
September 26, 2012Research and Development Jobs, Sanofi, pharma job cuts, restructuring
Sanofi is to cut 900 jobs in its French operations by 2015 – fewer than expected after widespread speculation this …
Novo Nordisk to expand Beijing R&D centre
September 25, 2012Research and Development, Sales and Marketing Beijing, China, Novo Nordisk, R&D
Novo Nordisk is investing $100 million into enlarging its R&D facilities in Beijing into a state-of-the-art centre. Located in the …
Boehringer closing Petersburg API plant
September 25, 2012Manufacturing and Production API, Boehringer, Petersburg, chemicals
Boehringer Ingelheim has decided to close down one of its active pharmaceutical ingredient (API) manufacturing facilities in the US because …
Pharma is recovering, says Moody’s
September 25, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Moody's, Plavix, austerity, generics, pharma
Credit ratings agency Moody’s believes that the travails of the past few years, when various big-selling drugs went off-patent, are …
Life Healthcare Communications appoints Lyndsey Wright
September 25, 2012Business Services, Medical Communications, Sales and Marketing Life healthcare communications, Lyndsey Wright
Life Healthcare Communications has expanded its client services department to meet demand with the appointment of a new senior account …
Eisai opens Fycompa UK manufacturing line
September 25, 2012Manufacturing and Production, Sales and Marketing Eisai, Fycompa
Eisai has opened a new solid dose production line for epilepsy drug Fycompa at its UK base in Hatfield, Hertfordshire. …
John LaMattina: Why was bapineuzamab moved into Phase III trials?
September 24, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AD, John LaMattina, Pfizer, bapineuzamab
The recent news that the Pfizer/J&J Alzheimer’s Disease drug, bapineuzumab (bapi), had failed in critical clinical trials resulted in great …
Contract research news in brief
September 24, 2012Research and Development AMRI, Celerion, Covance, GNS Healthcare, INC Research, Knopp Biosciences, PPD, Vitalea Bioscience
A round-up of recent developments in the contract research sector, including updates from Covance/GNS, AMRI, Celerion, PPD, INC Research and …
EC publishes trio of revised GMP Guide sections
September 24, 2012Manufacturing and Production EC, EU, GMP, ICH
The European Commission has published two revised chapters in its Good Manufacturing Practice (GMP) Guide, along with an update of …
Eliquis receives nod in AF
September 24, 2012Sales and Marketing BMS, CHMP, Eliquis, Pfizer, Pradaxa, Xarelto
Bristol-Myers Squibb and Pfizer have received a boost with the CHMP’s recommendation that their co-marketed oral anticoagulant Eliquis should gain …
CMO market on the up says new study
September 24, 2012Manufacturing and Production API, CMO, manufacturing
The global contract manufacturing market is expected to reach a value of nearly $48 billion this year on the back …
Amgen names Ray Jordan senior VP Corporate Affairs
September 24, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amgen, J&J, JJ, Ray Jordan
Amgen has announced the appointment of ex-J&J comms leader Ray Jordan to the new position of senior vice president, Corporate …
New possibility for Lilly erectile drug
September 24, 2012Sales and Marketing CHMP, Cialis, ED, hyperplasia, lilly
Eli Lilly’s erectile disfunction (ED) brand Cialis has been recommended to treat benign prostatic hyperplasia (BPH) in Europe. If the …
Pharma creates non-profit R&D organisation
September 21, 2012Research and Development, Sales and Marketing Abbott, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly and Co, GlaxoSmithKline, Johnson & Johnson, Pfizer, R&D, Roche Genentech, Sanofi, TransCelerate BioPharma, biopharma
Ten biopharma companies have formed TransCelerate BioPharma Inc, a not-for-profit organisation using money and personnel from each firm, with a …
China sees fresh wave of drug price cuts
September 21, 2012Manufacturing and Production, Sales and Marketing China, Lunt, NDRC, ageing
China has unveiled yet another round of price cuts to prescription medicines. The price cuts cover more than 200 formulations …
Transgene appoints Nathalie Adda as chief medical officer
September 21, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Nathalie Adda, Transgene
Transgene has announced the appointment of Dr Nathalie Adda as chief medical officer. Responsible for medical and regulatory affairs of …
Merz Pharma slammed by PMCPA
September 21, 2012Medical Communications, Sales and Marketing ABPI, Merz Pharma, PMCPA
Merz Pharma UK has been rapped over the knuckles for three of the most serious breaches it is possible to …
Almirall’s COPD drug launched in Europe
September 20, 2012Sales and Marketing Advair, Almirall, Eklira, Genuair, Seretide, Spiriva
Almirall has launched COPD treatment Eklira in Denmark following approval from the European Commission. Phase III trials demonstrated that Eklira …
Latest content
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board
